Credit Suisse has slashed its earnings forecasts for Glaxosmithkline (GSK) before an expected restatement of divisional reporting at the pharmaceutical group. The bank has trimmed its target price for the stock from 1,475p to 1,400p and maintained an 'underperform' rating. It said that GSK's shares
Read more* GSK drug ahead of similar ones from Teva and AstraZeneca * Under-the-skin injection set for filing this year * NEJM editorial questions cost-effectiveness of new drugs * Analysts see fragmented market for biotech lung treatments (Adds more detail on Teva drug, analyst commen
Read more* GSK drug ahead of similar ones from Teva and AstraZeneca * Under-the-skin injection set for filing this year * Data on GSK's mepolizumab presented at Munich congress * NEJM editorial questions cost-effectiveness of new drugs By Ben Hirschler LONDON, Sept 8 (Reuters
Read moreConcerns surrounding the upcoming referendum on Scottish independence and a fragile ceasefire agreement in Ukraine were weighing heavily on UK stocks on Monday. London's FTSE 100 was trading down 1% at 6,789 by midday. The index has not closed below the 6,800 mark since 22 August when it settled at
Read more(For faster updates on individual market-movers, Eikon users please use search string "STXBZ US"; for more market insights, including options activity, ; for the Day Ahead newsletter, http://link.reuters.com/mex49s; for the Morning News Call newsletter, http://link.reuters.com/nex49s) U.S. stock
Read moreLONDON, Sept 8 (Reuters) - An experimental drug from AstraZeneca - part of a new wave of injectable respiratory drugs designed for people who do not respond adequately to traditional inhalers - has shown mixed results in chronic lung disease. Data published in The Lancet on Monday and being
Read moreBy Sharon Begley NEW YORK, Sept 7 (Reuters) - An experimental Ebola vaccine similar to one being developed by GlaxoSmithKline is effective for at least five weeks in lab monkeys but requires boosting with an additional vaccine to extend its protection to 10 months, according to a study publ
Read moreGENEVA, Sept 5 (Reuters) - The World Health Organisation (WHO) said on Friday that experts had agreed that blood-derived drug therapies and convalescent serum may be used for treatment of Ebola virus, and called for investment in the unproven drugs. Two "promising" Ebola vaccines have also
Read more* Clinical trials to test safety, efficacy of treatments * ZMapp president expects human trials to begin in 2015 * GSK vaccine clinical trials under way, data by year-end By Stephanie Nebehay GENEVA, Sept 5 (Reuters) - Drug and vaccine companies are racing to conduct clini
Read more